The debate over Alzheimer’s diagnosis: biological markers vs. symptoms
The field of Alzheimer’s disease (AD) is seeing a heated debate about the best way to diagnose this devastating condition. On one side, the Alzheimer Association (AA) proposed new criteria that rely solely on biological markers—such as proteins seen in brain scans or found in the liquid bathing the brain and spine, called cerebrospinal fluid (CSF)—even in individuals who show no symptoms. These biomarkers, which include amyloid and tau proteins, …
The debate over Alzheimer’s diagnosis: biological markers vs. symptoms
